Terguride Receives FDA Orphan Drug Designation For The Treatment Of Pulmonary Arterial Hypertension
01 Jul 2008
Decision Resources, one of the
world’s leading research and advisory firms focusing on pharmaceutical and
healthcare issues, Read the rest of this entry »